Statistics

Total Visits

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study32

Select a period of time:

Number of views in the range

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study10

Views

Views
August 20241
September 20241
October 20240
November 20241
December 20246
January 20251
February 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United Kingdom4
United States3
United Arab Emirates2
 

Top cities views

Views
London3